Xin Zhong-Tao, Beauchamp Adam D, Calado Rodrigo T, Bradford Jennifer W, Regal Joshua A, Shenoy Aarthi, Liang Yuying, Lansdorp Peter M, Young Neal S, Ly Hinh
Department of Pathology and Laboratory Medicine, Emory University, 105L Whitehead Biomedical Research Bldg, 615 Michael St, Atlanta, GA 30322, USA.
Blood. 2007 Jan 15;109(2):524-32. doi: 10.1182/blood-2006-07-035089. Epub 2006 Sep 21.
Human telomerase hTERC RNA serves as a template for the catalytic hTERT protein to synthesize telomere repeats at chromosome ends. We have recently shown that some patients with bone marrow failure syndromes are heterozygous carriers for hTERC or hTERT mutations. These sequence variations usually lead to a compromised telomerase function by haploinsufficiency. Here, we provide functional characterization of an additional 8 distinct hTERT sequence variants and 5 hTERC variants that have recently been identified in patients with dyskeratosis congenita (DC) or aplastic anemia (AA). Among the mutations, 2 are novel telomerase variants that were identified in our cohort of patients. Whereas most of the sequence variants modulate telomerase function by haploinsufficiency, 2 hTERC variants with sequence changes located within the template region appear to act in a dominant-negative fashion. Inherited telomerase gene mutations, therefore, operate by various mechanisms to shorten telomere lengths, leading to limited marrow stem cell reserve and renewal capacity in patients with hematologic disorders.
人端粒酶hTERC RNA作为催化性hTERT蛋白的模板,用于在染色体末端合成端粒重复序列。我们最近发现,一些骨髓衰竭综合征患者是hTERC或hTERT突变的杂合携带者。这些序列变异通常通过单倍体不足导致端粒酶功能受损。在此,我们对另外8种不同的hTERT序列变异体和5种hTERC变异体进行了功能表征,这些变异体最近在先天性角化不良(DC)或再生障碍性贫血(AA)患者中被鉴定出来。在这些突变中,有2种是在我们的患者队列中鉴定出的新型端粒酶变异体。虽然大多数序列变异通过单倍体不足调节端粒酶功能,但2种模板区域内有序列变化的hTERC变异体似乎以显性负性方式起作用。因此,遗传性端粒酶基因突变通过多种机制作用于缩短端粒长度,导致血液系统疾病患者的骨髓干细胞储备和更新能力受限。